781 - 790 of 8580 Results
Title
Year
-
OPENTitle: Transportation innovation to aid Parkinson disease trial recruitmentJournal Name: Contemporary Clinical Trials CommunicationsPublisher: Elsevier BVVol: 16Issue #:Start Page: 100449End Page: 100449Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.conctc.2019.100449Best OA location URL: https://doi.org/10.1016/j.conctc.2019.100449Citation Count: 9
-
RESTRICTEDTitle: Hypertension and progressive supranuclear palsyJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 66Issue #:Start Page: 166End Page: 170Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.07.036Citation Count: 19
-
OPENTitle: Comparison of voluntary and reflex cough effectiveness in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 20Issue #: 11Start Page: 1226End Page: 1230Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2014.09.010Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5450039Citation Count: 46
-
OPENTitle: Concomitant pathologies among a spectrum of parkinsonian disordersJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 20Issue #: 5Start Page: 525End Page: 529Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2014.02.012Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/4028418Citation Count: 141
- Intracellular Target-Specific Accretion of Cell Penetrating Peptides and Bioportides: Ultrastructural and Biological Correlates2015RESTRICTEDTitle: Intracellular Target-Specific Accretion of Cell Penetrating Peptides and Bioportides: Ultrastructural and Biological CorrelatesJournal Name: Bioconjugate ChemistryPublisher: American Chemical Society (ACS)Vol: 27Issue #: 1Start Page: 121End Page: 129Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/acs.bioconjchem.5b00529Citation Count: 17
- PPM1M, an LRRK2-counteracting, phosphoRab12-preferring phosphatase with a potential link to Parkinson’s disease2025RESTRICTEDTitle: PPM1M, an LRRK2-counteracting, phosphoRab12-preferring phosphatase with a potential link to Parkinson’s diseaseJournal Name: Cell ReportsPublisher: Elsevier BVVol: 44Issue #: 8Start Page: 116031End Page: 116031Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.celrep.2025.116031Best OA location URL: https://www.cell.com/cell-reports/pdf/S2211-1247(25)00802-2.pdfCitation Count: 0
-
OPENTitle: PDKit: A data science toolkit for the digital assessment of Parkinson’s DiseaseJournal Name: PLOS Computational BiologyPublisher: Public Library of Science (PLoS)Vol: 17Issue #: 3Start Page: e1008833End Page: e1008833Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pcbi.1008833Best OA location URL: https://doi.org/10.1371/journal.pcbi.1008833Citation Count: 5
- Site-Specific Phospho-Tau Aggregation-Based Biomarker Discovery for AD Diagnosis and Differentiation2022RESTRICTEDTitle: Site-Specific Phospho-Tau Aggregation-Based Biomarker Discovery for AD Diagnosis and DifferentiationJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 13Issue #: 23Start Page: 3281End Page: 3290Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/acschemneuro.2c00342Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/12316044Citation Count: 11
-
OPENTitle: miR-34a: a new player in the regulation of T cell function by modulation of NF-κB signalingJournal Name: Cell Death & DiseasePublisher: Springer Science and Business Media LLCVol: 10Issue #: 2Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41419-018-1295-1Best OA location URL: https://www.nature.com/articles/s41419-018-1295-1.pdfCitation Count: 67
- Assessment of executive function declines in presymptomatic and mildly symptomatic familial frontotemporal dementia: NIH‐EXAMINER as a potential clinical trial endpoint2019OPENTitle: Assessment of executive function declines in presymptomatic and mildly symptomatic familial frontotemporal dementia: NIH‐EXAMINER as a potential clinical trial endpointJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 16Issue #: 1Start Page: 11End Page: 21Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.jalz.2019.01.012Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1016/j.jalz.2019.01.012Citation Count: 40